Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 11 of 11 for “"Ibudilast"”.

  1. Glial Cell Modulators and Associated Anti-Inflammatory Activity: Implications in Reducing Methamphetamine Abuse-Related Behaviors in Rodents

    … of the present work was to assess the ability of ibudilast, AV1013, and minocycline, three glial cell modulating compounds, to attenuate responding in rodent procedures that model different aspects of methamphetamine abuse-related behavior. First, Ibudilast (1.8, 7.5, 13 mg/kg) and AV1013 (10, 30, …

    vcu Repository record for Glial Cell Modulators and Associated Anti-Inflammatory Activity: Implications in Reducing Methamphetamine Abuse-Related Behaviors in Rodents (opens in a new tab)

  2. Codeine, heightened pain sensitivity and medication overuse headache: a neuroimmune hypothesis and novel treatment strategy.

    … the efficacy of a glial-attenuating treatment, ibudilast, in the clinical management of medication overuse headache induced by opioid use in a double-blind, randomised, placebo-controlled parallel group study. Patients received ibudilast 40 mg twice daily or placebo for I weeks and recorded …

    adelaide Repository record for Codeine, heightened pain sensitivity and medication overuse headache: a neuroimmune hypothesis and novel treatment strategy. (opens in a new tab)

  3. Potential peripheral biomarkers for chronic pain.

    … the efficacy of a novel treatment for headache (ibudilast). This study consisted of MOH patients on 8 weeks of either placebo or ibudilast treatments. After 8 weeks of treatment, both groups did not experience a change in their headache frequency or intensity. However, a significant reduction in …

    adelaide Repository record for Potential peripheral biomarkers for chronic pain. (opens in a new tab)

  4. ASTROCYTE ACTIVATION AND ITS INFLUENCE ON THE BRAIN TUMOR MICROENVIRONMENT

    … with astrocyte activation attenuating drugs Ibudilast and Laquinimod are capable of reducing glioblastoma invasion in vitro. In addition, preliminary mouse work indicates that treatment with Ibudilast is capable of attenuating astrocyte activation in response to brain tumors in vivo.

    jhu Repository record for ASTROCYTE ACTIVATION AND ITS INFLUENCE ON THE BRAIN TUMOR MICROENVIRONMENT (opens in a new tab)

  5. Role of second generation phosphodiesterase inhibitors on mammalian sperm mobility

    … develop an animal IVF model to assess effects of Ibudilast on fertilization; and (4) optimise high performance liquid chromatography (HPLC) techniques for routine detection of cyclic nucleotides in sperm cells. A two phase drug screening approach was used to systematically and comprehensively …

    abertay Repository record for Role of second generation phosphodiesterase inhibitors on mammalian sperm mobility (opens in a new tab) Download PDF for Role of second generation phosphodiesterase inhibitors on mammalian sperm mobility (opens in a new tab)

  6. Novel Therapeutic Strategies for Alzheimer’s Disease: Targeting Toll-Like Receptor Signaling and a Multi-Target Approach

    … was that (1) targeting neuroinflammation with ibudilast (IBU) or (2) using a combined treatment with diazoxide (DZ) and dibenzoylmethane (DIB), will effectively slow down the progression of AD. IBU is a multi-target drug that is a non-selective phosphodiesterase inhibitor, a Toll-like receptor …

    cuny-grad Repository record for Novel Therapeutic Strategies for Alzheimer’s Disease: Targeting Toll-Like Receptor Signaling and a Multi-Target Approach (opens in a new tab)

  7. HTS (high-throughput drug screening) zur Untersuchung der Blut-Hirn-Schranken-Permeabilität in vitro beim zerebral metastasierten Mammakarzinom

    … nicht beeinflusst. GW2974 und Ibudilast zeigen bei 500 µM einen toxischen Einfluss auf MCF-7-Zellen. BLECs werden durch 100 µM GW2974 gehemmt. Es konnte gezeigt werden, dass die erhöhte Permeabilität mit einer Veränderung der TJ-Proteinexpression einhergeht. …

    wurz-thes Repository record for HTS (high-throughput drug screening) zur Untersuchung der Blut-Hirn-Schranken-Permeabilität in vitro beim zerebral metastasierten Mammakarzinom (opens in a new tab)

  8. Drug Repurposing Using Gene Expression Data Mining

    … a phenotypic screening pipeline to repurpose Ibudilast and MK-2206 for Alzheimer's Disease. Second, we have employed machine learning models to predict gene expression patterns perturbed by new chemicals in new cell types. The predicted gene expression profiles are used for drug repurposing …

    cuny-grad Repository record for Drug Repurposing Using Gene Expression Data Mining (opens in a new tab)

  9. Complement Proteins C1q and C3 in Astrocyte-Enriched Extracellular Vesicles as Biomarkers of Progressive Multiple Sclerosis Disease Progression

    … double-blind placebo-controlled trial of ibudilast in progressive MS (SPRINT-MS), using polymer precipitation followed by enrichment for AEVs (GLAST+) with immunoprecipitation. Complement components C1q and C3 were quantified using a multiple analyte bead assay. Disability was measured …

    jhu Repository record for Complement Proteins C1q and C3 in Astrocyte-Enriched Extracellular Vesicles as Biomarkers of Progressive Multiple Sclerosis Disease Progression (opens in a new tab) Embargoed until 2030-05-01

  10. Investigating neuroprotectants for the treatment of Chemotherapy-Induced Peripheral Neuropathy

    … several drugs selected from the literature (ibudilast, nicotinamide mononucleotide, resatorvid, amiloride, duloxetine, safinamide) for their potential neuroprotective effects in this model and of those, found that amiloride moderately but significantly prevented the reduction of neurite …

    unsw Repository record for Investigating neuroprotectants for the treatment of Chemotherapy-Induced Peripheral Neuropathy (opens in a new tab)